Brief: HBM Holdings Announces License Agreement With Windward Bio AG
10/01/2025 15:43
Jan 10 (Reuters) - Hbm Holdings Ltd 2142.HK :
* ENTERING INTO LICENSE AGREEMENT WITH WINDWARD BIO AG
* LICENSE AGREEMENT TO GRANT WINDWARD BIO AN EXCLUSIVE
WORLDWIDE
LICENSE TO MANUFACTURE, AMONG OTHERS, HBM9378/SKB378
* LICENSE AGREEMENT EXCLUDES GREATER CHINA AND SEVERAL
SOUTHEAST
AND WEST ASIAN COUNTRIES
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study